Institut Pasteur Korea (IPK) and ST Pharm announced an anti-influenza Drug Discovery project. This joint research project aims to discover novel influenza virus entry inhibitors with the potential to prevent or control the spread of influenza by blocking the initial entry step of viral life cycle. The project will take place over the next three years and the collaboration is supported by the Gyeonggi Provincial Government.


Source: HeraldBiz (September 27, 2016)